Inventor · disambiguated record
Philip E. Brandish
Also filed as: BRANDISH PHILIP E
9 granted patents·9 pending applications·16 citations·filing 2002–2022
80Inventor score
Top patents by PatentIndex Score
18 records- 0194US10550190B2Phosphate based linkers for intracellular delivery of drug conjugatesMERCK SHARP & DOHME·Filed 2015·Granted Feb 4, 2020·13 cites·4 claims
- 0284US11510993B2Antibody drug conjugate for anti-inflammatory applicationsMERCK SHARP & DOHME·Filed 2016·Granted Nov 29, 2022·3 cites·20 claims
- 0375US11883500B2Phosphonate linkers and their use to facilitate cellular retention of compoundsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 30, 2024·0 cites·20 claims
- 0471US12441792B2Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereofMERCK SHARP & DOHME·Filed 2021·Granted Oct 14, 2025·0 cites·13 claims
- 0571US12435133B2Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereofMERCK SHARP & DOHME LLC·Filed 2021·Granted Oct 7, 2025·0 cites·15 claims
- 0669US11111297B2Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Sep 7, 2021·0 cites·21 claims
- 0769US2023099074A1Antibody drug conjugate for anti-inflammatory applicationsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 0865US11554172B2Phosphonate linkers and their use to facilitate cellular retention of compoundsMERCK SHARP & DOHME·Filed 2020·Granted Jan 17, 2023·0 cites·7 claims
- 0962US10869929B2Phosphonate linkers and their use to facilitate cellular retention of compoundsMERCK SHARP & DOHME·Filed 2017·Granted Dec 22, 2020·0 cites·5 claims
- 1057US2025186539A2Methods for treating cancerBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 1153US2011003862A13-Animopyraolines for Treatment of Neurodegenerative and Psychiatric DiseasesMERCK SHARP & DOHME·Filed 2007·Application pending·0 cites
- 1246US2024317854A1Methods for treating cancer with anti-ilt3 antibodiesBRANDISH PHILIP E·Filed 2022·Application pending·0 cites
- 1345US2023058779A1Combination cancer treatment using a pd-1 antagonist, an ilt4 antagonist, and lenvatinib or salts thereofMERCK SHARP & DOHME LLC·Filed 2020·Application pending·0 cites
- 1445US2023050449A1Methods for treating cancer using a combination of a pd-1 antagonist, an ilt4 antagonist, and chemotherapeutic agentsMERCK SHARP & DOHME LLC·Filed 2020·Application pending·0 cites
- 1539US2004180394A1Assays for inositol phosphatesFiled 2002·Application pending·0 cites
- 1635US2010261765A1Mineralocorticoid receptor modulatorsBRANDISH PHILIP E·Filed 2008·Application pending·0 cites
- 1734US8063090B2Mineralocorticoid receptor modulatorsBRANDISH PHILIP E·Filed 2008·Granted Nov 22, 2011·0 cites·11 claims
- 1834US2009306169A1Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase InhibitorsBRANDISH PHILIP E·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →